These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Rader DJ Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure control, glycemic control, and dyslipidemia among healthy adults in the Cape Coast metropolis, Ghana. Gato WE; Acquah S; Nsiah P; Opoku ST; Apenteng BA; Johnson BK Diabetes Metab Syndr; 2019; 13(1):56-61. PubMed ID: 30641765 [TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Vasudevan AR; Ballantyne CM Clin Cornerstone; 2005; 7(2-3):7-16. PubMed ID: 16473256 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance: the link between obesity and cardiovascular disease. Reaven GM Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697 [TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. Gerich JE Clin Cornerstone; 2007; 8(3):53-68. PubMed ID: 18452842 [TBL] [Abstract][Full Text] [Related]
14. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Sowers JR; Frohlich ED Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051 [TBL] [Abstract][Full Text] [Related]
15. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome. Ferdinand KC J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832 [TBL] [Abstract][Full Text] [Related]
16. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. Abate N J Diabetes Complications; 2000; 14(3):154-74. PubMed ID: 10989324 [TBL] [Abstract][Full Text] [Related]